Preferred Label : Methemoglobinemia due to deficiency of methemoglobin reductase;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Nadh-dependent methemoglobin reductase deficiency; Nadh-cytochrome b5 reductase deficiency; Methemoglobinemia, congenital, autosomal recessive;
Included titles and symbols : Methemoglobinemia, type I; Methemoglobinemia, type II; Nadh-cytochrome b5 reductase deficiency, type I; Nadh-cytochrome b5 reductase deficiency, type II;
Description : Methemoglobinemia due to NADH-cytochrome b5 reductase deficiency is an autosomal recessive
disorder characterized clinically by decreased oxygen carrying capacity of the blood,
with resultant cyanosis and hypoxia (review by Percy and Lappin, 2008). There are
2 types of methemoglobin reductase deficiency. In type I, the defect affects the soluble
form of the enzyme, is restricted to red blood cells, and causes well-tolerated methemoglobinemia.
In type II, the defect affects both the soluble and microsomal forms of the enzyme
and is thus generalized, affecting red cells, leukocytes, and all body tissues. Type
II methemoglobinemia is associated with mental deficiency and other neurologic symptoms.
The neurologic symptoms may be related to the major role played by the cytochrome
b5 system in the desaturation of fatty acids (Vives-Corrons et al., 1978; Kaplan et
al., 1979).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the cytochrome b5 reductase 3 gene (CYB5R3, 613213.0001);
Laboratory abnormalities : NADH-cytochrome b(5) reductase deficiency;
Prefixed ID : #250800;
Origin ID : 250800;
UMLS CUI : C5574660;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
Genes related to phenotype
HPO term(s)
Narrower ORDO disease(s)
ORDO concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT